The "Lollipop" During Catheter-Directed Thrombectomy: 2 Case Examples.

IVC, inferior vena cava PE, pulmonary embolism RHC, right heart catheterization complication pulmonary circulation thrombus

Journal

JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292

Informations de publication

Date de publication:
21 Dec 2022
Historique:
received: 14 08 2022
accepted: 15 09 2022
entrez: 23 1 2023
pubmed: 24 1 2023
medline: 24 1 2023
Statut: epublish

Résumé

Intraprocedural embolization has been described as a potential complication of catheter thrombectomy for acute pulmonary embolism and may be under-recognized. We describe 2 case examples of "Lollipopping" during thrombectomy, which may be a mechanism of intraprocedural embolization and describe our treatment approach. (

Identifiants

pubmed: 36684029
doi: 10.1016/j.jaccas.2022.09.029
pii: S2666-0849(22)00786-0
pmc: PMC9847234
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101667

Informations de copyright

© 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation.

Déclaration de conflit d'intérêts

Dr Sethi has received honoraria from Janssen and Chiesi Inc. Dr Leon has served as a nonpaid advisory board member and receives institutional clinical research grants from Abbott, Boston Scientific, Medtronic, and Sinomed. Dr Kirtane has received institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Amgen, CSI, Philips, ReCor Medical, Neurotronic, Biotronik, Chiesi, Bolt Medical, Magenta Medical, Canon, SoniVie, and Merck (institutional funding includes both research grants and fees paid to Columbia University and/or Cardiovascular Research Foundation for consulting and/or speaking engagements in which Dr Kirtane controlled the content); has served as a consultant for IMDS; and has received travel expenses/meals from Medtronic, Boston Scientific, Abbott Vascular, CSI, Siemens, Philips, ReCor Medical, Chiesi, OpSens, Zoll, and Regeneron. Dr Parikh has received institutional grants/research support from Abbott Vascular, Shockwave Medical, TriReme Medical, Sumodics, Silk Road Medical, and the National Institutes of Health; has received consulting fees from Terumo and Abiomed; and has served on the Advisory Boards of Abbott, Medtronic, Boston Scientific, CSI, Janssen, and Philips. Dr Finn has received speaker fees from Janssen. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Références

JACC Cardiovasc Interv. 2019 May 13;12(9):859-869
pubmed: 31072507
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619853037
pubmed: 31185730
Circulation. 2019 Nov 12;140(20):e774-e801
pubmed: 31585051

Auteurs

Daniella Concha (D)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Sanjum S Sethi (SS)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Navneet Sharma (N)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Koji Takeda (K)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Anthony Pucillo (A)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Martin B Leon (MB)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Erika Berman-Rosenzweig (E)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Ajay J Kirtane (AJ)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Sahil A Parikh (SA)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Matthew T Finn (MT)

Columbia University Irving Medical Center/New York Presbyterian Hospital, Center for Interventional Vascular Therapy, New York, New York, USA.

Classifications MeSH